Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

SHE:002864 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,012	971.45	978.2	971.04	883.76	667.66
Other Revenue	2.41	2.41	2.63	3.26	3.73	2.66
Revenue	1,014	973.86	980.83	974.29	887.48	670.31
Revenue Growth (YoY)	5.04%	-0.71%	0.67%	9.78%	32.40%	9.77%
Cost of Revenue	417.1	381.74	413.74	408.25	370.36	255.52
Gross Profit	596.86	592.12	567.09	566.04	517.12	414.79
Selling, General & Admin	434.22	436.86	418.79	416.11	386.15	305.6
Research & Development	38.46	37.54	20.26	18.23	14.03	12.97
Other Operating Expenses	9.73	9.35	10.61	10.23	9.29	7.15
Operating Expenses	484.54	485.59	453.98	452.94	414.07	329.39
Operating Income	112.32	106.53	113.11	113.1	103.05	85.39
Interest Expense	-1.48	-1.56	-6.11	-13.92	-3.49	-2.85
Interest & Investment Income	24.96	25.58	22.06	17.18	11.78	8.32
Other Non Operating Income (Expenses)	-5.2	-0.22	0.31	2.55	-5.27	1.19
EBT Excluding Unusual Items	130.59	130.32	129.37	118.91	106.06	92.06
Gain (Loss) on Sale of Investments	-	-	-1.56	-0.11	-	-
Gain (Loss) on Sale of Assets	-0.02	-0.01	0.17	-	-	0.15
Asset Writedown	0.14	-0.18	-0.81	-0.08	-0	-0.19
Other Unusual Items	6.82	6.82	2.08	0.46	2.97	2.49
Pretax Income	137.53	136.95	129.25	119.18	109.03	94.5
Income Tax Expense	17.5	17.03	17.7	16.03	14.47	13.4
Earnings From Continuing Operations	120.03	119.92	111.55	103.15	94.56	81.09
Minority Interest in Earnings	0.34	0.35	-1.11	-1.98	-1.39	-1.98
Net Income	120.37	120.27	110.43	101.16	93.17	79.12
Net Income to Common	120.37	120.27	110.43	101.16	93.17	79.12
Net Income Growth	0.30%	8.91%	9.16%	8.58%	17.77%	10.22%
Shares Outstanding (Basic)	105	105	96	86	85	86
Shares Outstanding (Diluted)	105	105	98	86	85	86
Shares Change (YoY)	4.41%	7.02%	13.03%	1.16%	-0.60%	-0.56%
EPS (Basic)	1.15	1.15	1.15	1.18	1.09	0.92
EPS (Diluted)	1.15	1.15	1.13	1.17	1.09	0.92
EPS Growth	-3.94%	1.77%	-3.42%	7.34%	18.48%	10.84%
Free Cash Flow	39.98	74.54	41.53	69.53	35.36	21.06
Free Cash Flow Per Share	0.38	0.71	0.42	0.80	0.41	0.24
Dividend Per Share	0.250	0.250	0.220	0.200	0.180	0.150
Dividend Growth	13.64%	13.64%	10.00%	11.11%	20.00%	-
Gross Margin	58.86%	60.80%	57.82%	58.10%	58.27%	61.88%
Operating Margin	11.08%	10.94%	11.53%	11.61%	11.61%	12.74%
Profit Margin	11.87%	12.35%	11.26%	10.38%	10.50%	11.80%
Free Cash Flow Margin	3.94%	7.65%	4.23%	7.14%	3.98%	3.14%
EBITDA	145.48	139.02	142.92	130.16	117.8	99.85
EBITDA Margin	14.35%	14.27%	14.57%	13.36%	13.27%	14.89%
D&A For EBITDA	33.16	32.49	29.81	17.07	14.74	14.45
EBIT	112.32	106.53	113.11	113.1	103.05	85.39
EBIT Margin	11.08%	10.94%	11.53%	11.61%	11.61%	12.74%
Effective Tax Rate	12.72%	12.43%	13.70%	13.45%	13.27%	14.19%
Revenue as Reported	1,014	973.86	980.83	974.29	887.48	670.31
Advertising Expenses	-	5.04	1.09	1.76	3.68	0.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.